Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Finasteride may help reduce prostate cancer risk.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Long-term use of finasteride may cause breast cancer in men.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Selenium supplements do not prevent cancer and may increase certain health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Large prostate links to more hair loss, but age of onset doesn't affect it.